德国跨诊断样本中自恋维度与抑郁症状在认知行为治疗与精神分析交互治疗中的前瞻性队列研究
该研究在德国两个独立成人样本中考察自恋维度(钦佩与竞争)对抑郁症状及治疗结局的影响。结果显示自恋竞争与基线抑郁症状负荷较高相关,自恋钦佩呈相反效应;核心自恋和竞争预测CBT治疗反应较差,而PIT中未见自恋对治疗结局的影响。治疗联盟在门诊CBT样本中中介了自恋对治疗后抑郁严重程度的影响。
要点
- 自恋竞争与基线抑郁症状较高相关,自恋钦佩则与较低抑郁症状相关。
- 核心自恋和自恋竞争预测CBT治疗反应较差,自恋钦佩无此效应。
- PIT中未观察到自恋对治疗结局的影响。
核心结论
- 自恋维度评估应纳入未来研究和临床常规,治疗联盟和治疗策略可指导治疗选择。
研究设计与样本
- 自然观察性前瞻性队列研究,两个独立成人样本:CBT组含住院和门诊患者,PIT组为住院患者。
主要发现
- PIT中未发现自恋对治疗结局的影响。
- 门诊CBT样本中治疗联盟中介了自恋对治疗后抑郁严重程度的影响。
关键数值与推荐
- 自恋钦佩与竞争用Narcissistic Admiration and Rivalry Questionnaire-short version测量。
- 抑郁症状用Beck's Depression Inventory和Patient Health Questionnaire-Depression Scale测量。
临床怎么用
- 临床中可考虑对自恋维度进行评估,尤其在接受CBT的抑郁患者中。
- 关注治疗联盟可能有助于改善自恋相关治疗反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Narcissistic personality traits have been theorised to negatively affect depressive symptoms, therapeutic alliance, and treatment outcome, even in the absence of narcissistic personality disorder. We aimed to examine how the dimensional narcissistic facets of admiration and rivalry affect depressive symptoms across treatment modalities in two transdiagnostic samples. METHODS: We did a naturalistic, observational prospective cohort study in two independent adult samples in Germany: one sample pooled from an inpatient psychiatric clinic and an outpatient treatment service offering cognitive behavioural treatment (CBT), and one sample from an inpatient clinic providing psychoanalytic interactional therapy (PIT). Inpatients treated with CBT had an affective or psychotic disorder. For the other two sites, data from all service users were collected. We examined the effect of core narcissism and its facets admiration and rivalry, measured by Narcissistic Admiration and Rivalry Questionnaire-short version, on depressive symptoms, measured by Beck's Depression Inventory and Patient Health Questionnaire-Depression Scale, at baseline and after treatment in patients treated with CBT and PIT. Primary analyses were regression models, predicting baseline and post-treatment depression severity from core narcissism and its facets. Mediation analysis was done in the outpatient CBT group for the effect of the therapeutic alliance on the association between narcissism and depression severity after treatment. FINDINGS: The sample included 2371 patients (1423 [60·0%] female and 948 [40·0%] male; mean age 33·13 years [SD 13·19; range 18-81), with 517 inpatients and 1052 outpatients in the CBT group, and 802 inpatients in the PIT group. Ethnicity data were not collected. Mean treatment duration was 300 days (SD 319) for CBT and 67 days (SD 26) for PIT. Core narcissism did not predict depression severity before treatment in either group, but narcissistic rivalry was associated with higher depressive symptom load at baseline (β 2·47 [95% CI 1·78 to 3·12] for CBT and 1·05 [0·54 to 1·55] for PIT) and narcissistic admiration showed the opposite effect (-2·02 [-2·62 to -1·41] for CBT and -0·64 [-1·11 to -0·17] for PIT). Poorer treatment response was predicted by core narcissism (β 0·79 [0·10 to 1·47]) and narcissistic rivalry (0·89 [0·19 to 1·58]) in CBT, whereas admiration showed no effect. No effect of narcissism on treatment outcome was discernible in PIT. Therapeutic alliance mediated the effect of narcissism on post-treatment depression severity in the outpatient CBT sample. INTERPRETATION: As narcissism affects depression severity before and after treatment with CBT across psychiatric disorders, even in the absence of narcissistic personality disorder, the inclusion of dimensional assessments of narcissism should be considered in future research and clinical routines. The relevance of the therapeutic alliance and therapeutic strategy could be used to guide treatment approaches. FUNDING: IZKF Münster. TRANSLATION: For the German translation of the abstract see Supplementary Materials section.
引用
- Richter M, Mota S, Hater L, et al. Narcissistic dimensions and depressive symptoms in patients across mental disorders in cognitive behavioural therapy and in psychoanalytic interactional therapy in Germany: a prospective cohort study. Lancet Psychiatry. 2023. PMID: 37844592. doi:10.1016/S2215-0366(23)00293-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。